Checkpoint Therapeutics
Waltham, US · Founded 2014 · Delaware corporation
Find your way into Checkpoint Therapeutics
Sign up to see every warm intro you have to Checkpoint Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Checkpoint Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
MW
Michael WeissBoard director
LA
Lindsay A. RosenwaldBoard director
BS
Barry SalzmanBoard director
AS
Amit SharmaBoard director
NH
Neil HerskowitzBoard director
CB
Christian BechonBoard director
SB
Scott BoilenBoard director
Reported raises · per SEC filings
Form D private placements$57.8M disclosed across 1 of 5 rounds · 2015–2024
▶Undisclosed amountofferedJul 2024 · 1 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedJul 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Barry SalzmanDirector
- Michael WeissDirector
- Amit SharmaDirector
- Neil HerskowitzDirector
- Christian BechonDirector
- Lindsay A. RosenwaldDirector
- James F. Oliviero, IIIExecutive Officer, Director
- Garrett GrayExecutive Officer
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedFeb 2024 · 1 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedFeb 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Garrett GrayExecutive Officer
- James F. Oliviero, IIIExecutive Officer, Director
- Michael WeissDirector
- Christian BechonDirector
- Lindsay A. RosenwaldDirector
- Barry SalzmanDirector
- Neil HerskowitzDirector
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedApr 2023 · 9 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedApr 2023 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christian BechonDirector
- Lindsay A. RosenwaldDirector
- Garrett GrayExecutive Officer
- Neil HerskowitzDirector
- Michael WeissDirector
- Barry SalzmanDirector
- James F. Oliviero, IIIExecutive Officer, Director
- Scott BoilenDirector
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedMar 2023 · 1 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedMar 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James F. Oliviero, IIIExecutive Officer, Director
- Garrett GrayExecutive Officer
- Michael WeissDirector
- Neil HerskowitzDirector
- Scott BoilenDirector
- Barry SalzmanDirector
- Christian BechonDirector
- Lindsay A. RosenwaldDirector
- Placement agents
- H.C. Wainwright & Co.
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$57.8MraisedSep 2016 · 559 investors · BiotechnologyRule 506(b)
▶$57.8MraisedSep 2016 · 559 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lindsay A. RosenwaldDirector
- David J. HorinExecutive Officer
- Michael S. WeissDirector
- James F. Oliviero, IIIExecutive Officer
- Neil HerskowitzDirector
- Scott BoilenDirector
- Barry SalzmanDirector
- Offering amount
- $62.5M
- Amount sold
- $57.8M
- Sales commissions
- $5.8M
- Placement agents
- National Securities Corporation
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Checkpoint Therapeutics raised?
- Checkpoint Therapeutics has disclosed $57.8M raised across 1 of its 5 known rounds.
- Where is Checkpoint Therapeutics headquartered?
- Checkpoint Therapeutics is headquartered in Waltham, US.
